Product NDC 55513-0112

3 active presentations under this Product NDC family.

Review package-specific NDC rows, compare configurations, and request pricing through the RFQ workflow.

Need a Product Not Listed?

Submit a custom quote request for unlisted NDCs, item codes, or alternate product presentations.

Drug Catalog Search | Request a Custom Quote

Family context

Product NDC 55513-0112 groups closely related presentations under the same catalog family, giving healthcare teams a clearer path for comparing packaging and alternate exact NDC rows before an RFQ is submitted.

  • Family size: 3 active presentations.
  • Generic family: tezepelumab-ekko.
  • Primary dosage form: Injection.
  • Common strength: 210 mg / 1.9mL.

What changes inside this family

Use the family page to compare formats, then click into the exact NDC page that matches the package your team needs.

  • Manufacturers shown: Amgen Inc.
  • Dosage forms shown: Injection.
  • Package quantities: 1 Syringe and 1.91 mL.

Manufacturer pathways

Official family references

Use official family-level references to verify labeling context while comparing the child NDC presentations shown on this page.

Showing page 1 of 1
tezepelumab-ekko 210 mg / 1.9mL Injection 1.91 mL (Tezspire)55513-0112-01210 mg / 1.9mLInjection1 Syringe
tezepelumab-ekko 210 mg / 1.9mL Injection 1.91 mL (Tezspire)55513-0112-96210 mg / 1.9mLInjection1 Syringe
tezepelumab-ekko 210 mg / 1.9mL Injection 1.91 mL (Tezspire)55513-0112-99210 mg / 1.9mLInjection1.91 mL

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.